Ambrisentan and Papilloedema - a phase IV clinical study of FDA data

Summary:

Papilloedema is reported as a side effect among people who take Ambrisentan (ambrisentan), especially for people who are female, 30-39 old, have been taking the drug for 1 - 2 years also take Adcirca, and have Primary pulmonary hypertension.

The phase IV clinical study analyzes which people have Papilloedema when taking Ambrisentan. It is created by eHealthMe based on reports of 61,294 people who have side effects when taking Ambrisentan from the FDA, and is updated regularly.

What is Ambrisentan?

Ambrisentan has active ingredients of ambrisentan. eHealthMe is studying from 61,368 Ambrisentan users. Check the latest studies of Ambrisentan.

What is Papilloedema?

Papilloedema (optic disc swelling) is found to be associated with 501 drugs and 775 conditions by eHealthMe. Check the latest studies of Papilloedema.

On Aug, 01, 2026

61,294 people reported to have side effects when taking Ambrisentan.
Among them, 11 people (0.02%) have Papilloedema.

Among these 11 people:

How long have people been on Ambrisentan when they have Papilloedema? *

What is the gender of people who have Papilloedema when taking Ambrisentan? *

female: 100 %
male: 0.0 %

What is the age of people who have Papilloedema when taking Ambrisentan? *

What are other drugs people take besides Ambrisentan? *

What are other side effects people have besides Papilloedema? *

Cataract (clouding of the lens inside the eye): 3 people, 27.27%
Vision Blurred: 2 people, 18.18%
Cellulitis (infection under the skin): 2 people, 18.18%
Finger Deformity (a deformed position of the finger): 2 people, 18.18%
Headache (pain in head): 2 people, 18.18%
Uveitis (inflammation of the uvea): 2 people, 18.18%
Ingrowing Nail: 2 people, 18.18%
Joint Pain: 2 people, 18.18%
Liver Disorder (liver diseases): 2 people, 18.18%
Osteolysis (dissolution of bone): 2 people, 18.18%

What are the existing conditions these people have? *

Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 6 people, 54.55%
Skin Ulcer: 2 people, 18.18%
Pulmonary Hypertension (increase in blood pressure in the lung artery): 2 people, 18.18%
Dry Mouth: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Ambrisentan and have Papilloedema?

- Check whether Papilloedema is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ambrisentan:

Ambrisentan (61,368 reports)

Papilloedema treatments and more:

Papilloedema (6,266 reports)

Browse all side effects of Ambrisentan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Papilloedema:

Papilloedema (501 drugs)

Browse all the conditions that are associated with Papilloedema:

Papilloedema (775 conditions)

Related publications that referenced our studies

Dulani S, Dulani R, Lele S, Diagavane S, Anjankar S, Jaiswal N, Subramaniam PS, Juneja R, "Chronic Subdural Haematoma in a Case of Hyperthyroidism Presenting with Papilledema", Chinese Medicine, 2012 Dec .
Dulani S, Dulani R, Lele S, Diagavane S, Anjankar S, Jaiswal N, Subramaniam PS, Juneja R, "Chronic Subdural Haematoma in a Case of Hyperthyroidism Presenting with Papilledema", Chinese Medicine, 2012 Dec .

How the study uses the data?

The study uses data from the FDA. It is based on ambrisentan (the active ingredients of Ambrisentan) and Ambrisentan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.